Aptamers may be employed in tumor-targeted treatment to overcome multidrug resistance because they may effectively distribute aptamer-mediated nanoparticles into cancer cells of the ovary and overcome multidrug resistance brought on by VEGF. This evidence concerns the gene VEGFA and cancer.